Investigation of synergistic effects of curcumin with some antibiotics in extended spectrum beta lactamase positive or negative escherichia coli and klebsiella pneumoniae isolates

Acta Medica Mediterranea

Volumn 29, Issue 4, 2013, Pages 761-765

  Gunes, Hayati ^a   Dogan, Mustafa ^a   Gumus, Abdullah ^a   Mutlu, Reyhan ^a   Topkaya, Aynur Eren ^a  

^a NAMIK KEMAL UNIVERSITY   (Turkey)

Author keywords

Curcumin; E. coli; Extended spectrum beta lactamase; Imipenem; K. pneumoniae

Indexed keywords

AMIKACIN; AMIKETEM; CIFLOSIN; CIPROFLOXACIN; CURCUMIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTA; GENTAMICIN; IMIPENEM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 84896705736     PISSN: 03936384     EISSN: 22839720     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and K. pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001; 32: 1162-71.
2. Özsoy MF, Öncül O, Yildirim A, Pahsa A. Extended-spectrum beta-lactamases: clinical significance and the attendant problems. Flora Derg. 2001; 6 (suppl 1): 3-23.
3. Dudhatra GB, Mody SK, Awale MM, Patel HB, Modi CM, Kumar A, et al. Comprehensive Review on Pharmacotherapeutics of Herbal Bioenhancers. ScientificWorldJournal 2012; 637953
4. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007; 595: 1-75.
5. Ammon HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Med. 1991; 57: 1.
6. Sharma M, Manoharlal R, Negi AS, Prasad R. Synergistic anticandidal activity of pure polyphenol curcuminI in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis. FEMS Yeast Res. 2010; 10: 570-8.
7. Nandakumar DN, Nagaraj VA, Vathsala PG, Rangarajan P, Padmanaban G. Curcuminartemisinin combination therapy for malaria. Antimicrob. Agents Chemother. 2006; 50: 1859-60
8. Rasmussen HB, Christensen SB, Kvist LP, Karazmi A. A simple and efficient separation of the curcumins, the antiprotozoal constituents of Curcuma longa. Planta Med. 2000; 66: 396-8.
9. Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y. Nematocidal activity of Turmeric: synergistic action of curcuminoids. Chem Pharm Bul. 1993; 4: 1640-3.
10. Mazumber A, Raghavan K, Weinstein J, Kohn KW, Pommer Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol. 1995; 49: 1165-70.
11. Erenoglu C, Kanter M, Aksu B, Sagiroglu T, Ayvaz S, Aktas C, et al. Protective effect of curcumin on liver damage induced by biliary obstruction in rats. Balkan Med J. 2011; 28: 352-7.
12. Aktas C, Kanter M, Kocak Z. Antiapoptotic and proliferative activity of curcumin on ovarian follicles in mice exposed to whole body ionizing radiation. Toxicol Ind Health. 2012; 28: 852-63.
13. Aktas C, Kanter M, Erboga M, Ozturk S. Antiapoptotic effects of curcumin on cadmiuminduced apoptosis in rat testes. Toxicol Ind Health. 2012; 28: 122-30.
14. Chopra RN, Gupta JC, Chopra GS. Pharmacological action of the essential oil of Curcuma longa. Indian J Med Res. 1941; 29: 769-72.
15. Bhavani Sankar TN, Murthy S. Effect of Turmeric (Curcuma longa) fractions on the growth of some intestinal and pathogenic bacteria in vitro. Indian J Exp Biol. 1979; 17: 1363-6.
16. Rudrappa T, Bais HP. Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. J Agric Food Chem. 2008; 56: 1955-62.
17. Gunes H, Gulen D, Mutlu R, Gumus A, Tas T, Eren Topkaya A. Antibacterial effects of curcumin: An in vitro minimum inhibitory concentration study. Toxicol Ind Health. DOI: 10.1177/0748233713498458 (Epub ahead of print).
18. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 21th Informational Supplement M100-S21, 2011. CLSI, Wayne, PA.
19. Satish KP, Moellering RCJ, Eliopoulus, GM. Antimicrobial combinations, p. 365-424. In: V. Lorian (ed.) Antibiotics in Laboratory Medicine, 2005; 5th ed. The Lippincott Williams & Wilkins Co. Baltimore, Md.
20. Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med. 2005; 352: 380-91.
21. Romero L, Lopez L, Rodriguez-Bano J, Hernández JR, Martínez M, Pascual A. Longterm study of the frequency of Escherichia coli and K. pneumoniae isolates producing extended spectrum beta-lactamases. Clin Microbiol Infect Dis. 2005; 11: 625-31.
22. Gür D, Gülay Z, Akan ÖA, Aktas Z, Bal Kayacan Ç, Çakici Ö, et al. Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: Results of the multicentre HITIT study. Microbiol Bul. 2008; 42: 537-44.
23. Baykal A, Coplu N, Simsek H, Esen B, Gur D. Investigation of the presence of extended spectrum beta-lactamase, kpc-type carbapenemase and plasmid-mediated ampc beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures. Mikrobiyol Bul. 2012; 46: 159-69.
24. Maltezou HC. Metallo-beta-lactamases in Gramnegative bacteria: introducing the era of panresistance? Int J Antimicrob Agents. 2009; 33: 405-e1-7.
25. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007; 51: 763-5.
26. Kuzucu C, Yetkin F, Görgeç S, Ersoy Y. Investigation of the susceptibilities of extendedspectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems. Mikrobiyol Bul. 2011; 45: 28-35.
27. Long C, Miao J, Cui L. Cytotoxic effect of curcumin on malaria parasite plasmodium falciparum: Inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob Agents Chemother. 2007; 51: 488-94.
28. Bansal S, Chhibber S. Curcumin alone and in combination with augmentin protects against pulmonary inflammation and acute lung injury generated during K. pneumoniae B5055-induced lung infection in BALB/c mice. J Med Microbiol. 2010; 59: 429-37.
29. Strimpakos AS, Sharma RA. Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trial. s Antioxid Redox Signal. 2008; 10: 511-45.
30. Epstein J, Sanderson IR, Macdonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr. 2010; 103: 1545-57.